Status:
NOT_YET_RECRUITING
Idiopathic Pulmonary Fibrosis Cohort of TCM
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Collaborating Sponsors:
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
China-Japan Friendship Hospital
Conditions:
Idiopathic Pulmonary Fibrosis (IPF)
Eligibility:
All Genders
40+ years
Brief Summary
This study, based on past registration records, evaluates the clinical efficacy of traditional Chinese medicine in treating IPF in the real world, identifies advantageous populations and clinical targ...
Detailed Description
This study is based on a previously established registry of interstitial lung disease, with traditional Chinese medicine treatment as the exposure factor. A total of at least 1000 IPF patients will be...
Eligibility Criteria
Inclusion
- Patients diagnosed with IPF;
- Age ≥ 40 years old;
- Voluntary participation in this study,And sign the informed consent form.
Exclusion
- Patients with confusion, dementia, consciousness disorders, and various mental illnesses;
- Patients who are unable to take care of themselves and have been bedridden for a long time.
Key Trial Info
Start Date :
September 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07162870
Start Date
September 5 2025
End Date
November 30 2028
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, China, 450000